We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Curing Cancer with CRISPR

News   Mar 22, 2017 | Original story from the National Cancer Institute

 
Curing Cancer with CRISPR

Mesothelin-specific CAR T cells attacking a cancer cell. Credit: Prasad Adusumilli / Memorial Sloan Kettering

 
 
 

RELATED ARTICLES

Bioactive Agents Improve Synthetic Bone Substitutes

News

Synthetic bone substitutes are promising materials for bone defect repair, but their efficacy can be substantially improved by bioactive agents such as growth factors. In a new study, researchers have modified beta-tricalcium phosphate (β-TCP) with increasing quantities of bone morphogenetic protein 2 (BMP-2) derived from E. coli and shown improved bone healing.

READ MORE

It Is Possible to Extend Life Without Any Genetic Modification, Study Suggests

News

Given the relationship between telomeres and ageing - telomeres shorten throughout life, so older organisms have shorter telomeres -, scientists launched a study generating mice in which 100% of their cells had hyper-long telomeres.

READ MORE

Drug Treats Inflammation Related to Genetic Heart Disease

News

Johns Hopkins researchers have shed new light on the role of the immune system in the progression of arrhythmogenic cardiomyopathy (ACM) and have also discovered a drug that may help prevent ACM symptoms and progression to heart failure.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE